SPY345.73+3.72 1.09%
DIA284.70+2.67 0.95%
IXIC11,605.07+126.19 1.10%

Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Lowers Price Target to $281

Morgan Stanley maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price target from $300 to $281.

· 10/13/2020 10:27
Morgan Stanley maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price target from $300 to $281.